ProfileGDS4718 / 220044_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 96% 94% 96% 97% 96% 94% 95% 95% 95% 96% 95% 97% 96% 95% 95% 95% 97% 96% 95% 94% 95% 96% 96% 96% 95% 98% 95% 96% 93% 96% 93% 96% 97% 97% 96% 94% 94% 95% 95% 96% 96% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.240595
GSM549102patient 115, normal, homogenized [OPG study]10.000494
GSM549104patient 119, normal, homogenized [OPG study]10.562696
GSM549108patient 138, normal, homogenized [OPG study]9.9278994
GSM549119patient 077, normal, homogenized [OPG study]10.654596
GSM549133patient 032, cancer, homogenized [OPG study]10.87797
GSM549139patient 042, cancer, homogenized [OPG study]10.626796
GSM549099patient 107, normal, homogenized [OPG study]9.9979294
GSM549109patient 139, normal, homogenized [OPG study]10.185995
GSM549110patient 046, normal, homogenized [OPG study]10.326995
GSM549114patient 063, normal, homogenized [OPG study]10.449295
GSM549122patient 082, normal, homogenized [OPG study]10.5596
GSM549134patient 033, cancer, homogenized [OPG study]10.17195
GSM549136patient 036, cancer, homogenized [OPG study]10.86397
GSM549140patient 044, cancer, homogenized [OPG study]10.489296
GSM549111patient 047, normal, homogenized [OPG study]10.43495
GSM549113patient 057, normal, homogenized [OPG study]10.379995
GSM549132patient 031, cancer, homogenized [OPG study]10.244995
GSM549137patient 038, cancer, homogenized [OPG study]10.621497
GSM549142patient 047, cancer, homogenized [OPG study]9.9892596
GSM549100patient 110, normal, homogenized [OPG study]10.273295
GSM549107patient 135, normal, homogenized [OPG study]10.173794
GSM549115patient 068, normal, homogenized [OPG study]10.578295
GSM549116patient 072, normal, homogenized [OPG study]10.57796
GSM549120patient 078, normal, homogenized [OPG study]10.562396
GSM549131patient 030, cancer, homogenized [OPG study]10.533196
GSM549118patient 074, normal, homogenized [OPG study]10.309995
GSM549129patient 027, cancer, homogenized [OPG study]11.287898
GSM549123patient 088, normal, homogenized [OPG study]10.404495
GSM549124patient 006, cancer, homogenized [OPG study]10.469796
GSM549126patient 015, cancer, homogenized [OPG study]9.6192693
GSM549128patient 025, cancer, homogenized [OPG study]10.426396
GSM549103patient 117, normal, homogenized [OPG study]9.8087193
GSM549117patient 073, normal, homogenized [OPG study]10.654196
GSM549138patient 041, cancer, homogenized [OPG study]10.778497
GSM549141patient 045, cancer, homogenized [OPG study]10.747797
GSM549130patient 028, cancer, homogenized [OPG study]10.299196
GSM549101patient 111, normal, homogenized [OPG study]9.9054394
GSM549105patient 128, normal, homogenized [OPG study]9.9095494
GSM549106patient 134, normal, homogenized [OPG study]10.473595
GSM549112patient 048, normal, homogenized [OPG study]10.397195
GSM549125patient 011, cancer, homogenized [OPG study]10.589596
GSM549127patient 024, cancer, homogenized [OPG study]10.281596
GSM549135patient 035, cancer, homogenized [OPG study]11.172198